Intelligent Fanatics Capital Management LLC sold $271k of MRAI
owner at Marpai, Inc.. 188,000 shares at an average of $1.44, traded Aug 13, 2025, filed Oct 17, 2025.
Score components
- +12Role10% owner
- +13Trade size$271k at market
- +5Share of holdings soldSold 10% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -27.3%, 3m -60.7%, 6m -80.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001798792-25-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 13, 2025 | SOpen-market sale Common Shares, par value $0.0001 | -10,000 | $1.43 | $14k | 1,854,707 | Oct 17, 2025 |
| Aug 15, 2025 | SOpen-market sale Common Shares, par value $0.0001 | -20,000 | $1.40 | $28k | 1,834,707 | Oct 17, 2025 |
| Aug 18, 2025 | SOpen-market sale Common Shares, par value $0.0001 | -20,000 | $1.40 | $28k | 1,814,707 | Oct 17, 2025 |
| Aug 19, 2025 | SOpen-market sale Common Shares, par value $0.0001 | -20,000 | $1.40 | $28k | 1,794,707 | Oct 17, 2025 |
| Aug 20, 2025 | SOpen-market sale Common Shares, par value $0.0001 | -10,000 | $1.42 | $14k | 1,784,707 | Oct 17, 2025 |
| Oct 6, 2025 | SOpen-market sale Common Shares, par value $0.0001 | -14,000 | $1.63 | $23k | 1,770,707 | Oct 17, 2025 |
| Aug 13, 2025 | SOpen-market sale Common Shares, par value $0.0001indirect: See Footnotes | -10,000 | $1.43 | $14k | 1,854,707 | Oct 17, 2025 |
| Aug 15, 2025 | SOpen-market sale Common Shares, par value $0.0001indirect: See Footnotes | -20,000 | $1.40 | $28k | 1,834,707 | Oct 17, 2025 |
| Aug 18, 2025 | SOpen-market sale Common Shares, par value $0.0001indirect: See Footnotes | -20,000 | $1.40 | $28k | 1,814,707 | Oct 17, 2025 |
| Aug 19, 2025 | SOpen-market sale Common Shares, par value $0.0001indirect: See Footnotes | -20,000 | $1.40 | $28k | 1,794,707 | Oct 17, 2025 |
| Aug 20, 2025 | SOpen-market sale Common Shares, par value $0.0001indirect: See Footnotes | -10,000 | $1.42 | $14k | 1,784,707 | Oct 17, 2025 |
| Oct 6, 2025 | SOpen-market sale Common Shares, par value $0.0001indirect: See Footnotes | -14,000 | $1.63 | $23k | 1,770,707 | Oct 17, 2025 |
Related signals
Other insiders at Marpai, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Marpai, Inc. | Steve Andrew Johnson Chief Financial Officer | $682 1,100 shares | +0% | |
| 26Weak | Marpai, Inc. | Yaron Eitan director | $2,700 10,000 shares | +1% | |
| 43Moderate | Marpai, Inc. | Yaron Eitan director | $100k 100,000 shares | +10% | |
| 40Moderate | Marpai, Inc. | Robert M Pons director | $50k 50,000 shares | +16% | |
| 28Weak | Marpai, Inc. | Sagiv Shiv director | $50k 50,000 shares | +23% | |
| 46Moderate | MRAIbuy Marpai, Inc. | Damien Lamendola Chief Executive Officer | $200k 147,058 shares | +2% | |
| 61Notable | MRAIbuy Marpai, Inc. | Damien Lamendola Chief Executive Officer | $950k 896,903 shares | +17% | |
| 53Moderate | MRAIbuy Marpai, Inc. | Damien Lamendola Chief Executive Officer | $400k 371,470 shares | +7% | |
| 39Weak | MRAIbuy Marpai, Inc. | Damien Lamendola Chief Executive Officer | $100k 86,805 shares | +2% | |
| 43Moderate | Marpai, Inc. | Yaron Eitan director | $125k 110,619 shares | +16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.